Prevention of arthropathy in haemophilia - Intensive on-demand treatment, UK perspective

  • Lee C
  • 10


    Mendeley users who have this article in their library.
  • 0


    Citations of this article.


In the past, there were only minimal studies aimed at establishing the dose of concentrate required for treating an acute joint bleed in patients without inhibitors. The cost of treatment with bypassing agents consumes huge economic resources and therefore it is important to have rigorous studies to establish rational dosing. Both the FEIBA NovoSeven Comparative study and the comparative dosing study have been bold attempts to clarify treatment regimens for managing joint bleeds in patients with inhibitors. As a very challenging situation in which to conduct research, it is important that such endeavour continues.

Author-supplied keywords

  • Arthropathy
  • Haemophilia
  • Intensive
  • On-demand treatment

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • C. A. Lee

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free